Skip to content

Longitudinal assessment of health-related quality of life in Japanese patients with advanced urothelial carcinoma receiving immune check point inhibitors

Longitudinal assessment of health-related quality of life in Japanese patients with advanced urothelial carcinoma receiving immune check point inhibitors

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1051230211
Enrollment
600
Registered
2024-03-28
Start date
2017-12-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urothelial carcinoma

Interventions

None listed

Sponsors

Miyake Makito
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Urothelial carcinoma Performance Status 0-3

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Health-related quality of life

Contacts

Public ContactMakito Miyake

Nara Medical University Hospital

makitomiyake@naramed-u.ac.jp+81-744223051

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026